GlassScriptPhysician profile
Timothy G Mock
NPI 1063961654
$3,554.56
in general payments reported to CMS, 2019-2025
16 companies · $1,018 in 2025
The $1,018 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $289 · 2020: $84.44 · 2021: $53.13 · 2022: $642 · 2023: $172 · 2024: $1,296 · 2025: $1,018.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,453 · Honoraria: $32.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,452.97 |
| Honoraria | $32.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $682.47 | 2024-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $546.30 | 2022-2025 | Lipiflow System Activator (Disposable) |
| Sun Pharmaceutical Industries INC. | $378.61 | 2023-2025 | Cequa |
| Dompe US, INC. | $331.59 | 2023-2024 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $319.32 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $284.25 | 2024-2025 | Infuse, Xiidra, Miebo |
| Alcon Vision LLC | $232.80 | 2019-2025 | Eysuvis, Tryptyr, Dailies Total1 |
| Tarsus Pharmaceuticals, INC. | $177.78 | 2024-2025 | Xdemvy |
| Coopervision INC. | $153.98 | 2019-2025 | Onefit Contact Lens, Myday Contact Lens |
| Rxsight INC | $127.29 | 2024-2025 | Rxsight Light Delivery Device (Ldd), Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Allergan, INC. | $124.67 | 2022 | |
| Oyster Point Pharma, INC. | $54.69 | 2023-2024 | Tyrvaya, Ryzumvi |
| Johnson & Johnson Vision Care, INC. | $46.14 | 2019-2024 | |
| Thea Pharma INC. | $39.02 | 2024-2025 | Iyuzeh |
| Harrow Eye, LLC | $35.82 | 2024 | Vevye |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tearlab Corp | $19.83 | 2023 | Tearlab Osmolarity System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Mock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.